Owen Mumford appoints new R&D director

Published by

Sam Pither

Oxford-based medical & pharmaceutical device manufacturers Owen Mumford have appointed Bal Johal as director of Research and Development.

Johal, whose previous experience includes time with Circassia, GlaxoSmithKline, Pfizer and Mundipharma Research Ltd, brings considerable experience covering a range of therapeutic areas and dosage forms.

Jarl Severn, managing director at Owen Mumford , said: “We welcome Bal very warmly into our business. She has the background, experience and drive to continue to accelerate the innovation and forward-thinking that will see us achieve ambitious growth and set us apart from the competition.”

The firm hopes Johal will further their long-term focus on research and development, expanding and improving their current product pipeline to deliver new ambitions in innovation, sustainable product design and life-cycle analysis to improve healthcare professional and patient experience.

Johal said, “To join Owen Mumford at this time is very exciting. With a combination of progress already made and some very talented people within the organisation, I can see that we will be able to deliver a high standard of success and innovation that will have a truly positive impact.”

Sam Pither

Sam is the Regional Editor of Biz News, responsible for both Hampshire and Dorset. A new recruit to journalism, Sam started writing for the Business Magazine as a freelancer in May of 2022 after completing his degree in English at University College London. His passion for local businesses and ability to tell a story soon caught the attention of the publication’s management team and have led to his meteoric rise. Sam, who lives in central Reading, takes a particular interest in technology, gaming and food and drink, having been a chef before starting his degree.